The Harbour Group insights

 

Read the macro investment strategy and asset allocation thinking behind your portfolio, penned by our in-house market strategist, Robin Gullason.

figure

Do Bull Markets Die of Old Age?

 December 19, 2025 - Peter Hannula

Read more
figure

The Cure for High Valuations Is Growth

 December 12, 2025 - Peter Hannula

Read more
figure

To Worry or Not? Can we learn to stop fretting and dance with uncertainty?

 November 14, 2025 - Peter Hannula

To Worry or Not? Can we learn to stop fretting and dance with uncertainty?

Read more
 

RBC insights

Discover the latest articles from thought leaders across our organization on everything from estate planning to philanthropy.

Executive summary: The biotech revolution and longevity

 September 05, 2025 |Frédérique Carrier

There’s more to a long life than simply a long lifespan. The number of years we spend in good health, or healthspan, is key. With biotech spurring promising medical innovations, we look at how it can fit into investment portfolios.

Read more

Life reimagined: The biotech revolution and longevity

 August 29, 2025 |Frédérique Carrier

There’s more to a long life than simply a long lifespan. The number of years we spend in good health, or healthspan, is key. With biotech spurring promising medical innovations, we look at how it can fit into investment portfolios.

Read more